Ibrance Prices - (palbociclib)

Savings Available Now for Drugs Awaiting Medicare Price Cuts in 2027 - February 12, 2025

Prescription drug costs in the U.S. remain one of the biggest financial burdens for millions of Americans—including Medicare beneficiaries. More than 5 million Medicare beneficiaries report difficulty affording their prescription medications, and 14% aged 65 or older skip taking or do not fill their prescriptions due to cost.

Breast Cancer Drugs 87% Cheaper Through International Mail Order - February 5, 2024

There is certainly more than enough physical and emotional stress surrounding a breast cancer diagnosis, but the United States healthcare system has decided financial strain should join the mix.

Medicare finally gets to throw its weight around. But for which medications? - September 6, 2022

Under the Inflation Reduction Act (IRA), Medicare is authorized to wield its purchasing power to negotiate lower prices on some of the most costly medications in the Part D and B programs.

Foreign-made Drugs Make Up Majority of Medicare Part D Spending On Specialty Drugs - May 24, 2022

An analysis of government data published in Health Affairs shows that more and more Medicare patients are taking new higher-priced specialty drugs, which has substantially increased Medicare’s spending on brand name drugs. These self-administered specialty drugs, covered under Medicare Part D, are medicines ranging from injectables, oral tablets, and inhalers.

Where Your Drug Is Made Depends On Who You Ask - March 30, 2022

Federal Law and Drug Labeling: Differing Definitions of An Imported Drug Your medication is – most likely – not made in the United States.  We reviewed the Food, Drug and Cosmetic Act (FDCA), the Tariff Act, and the Federal Trade Commission (FTC) Act because they each can affect how a drug manufacturer labels a drug product in terms of its country of origin.